Ginsenoside Ro Improves Cognitive Impairment and Neuroinflammation in APP/PS1 Mice via the IBA1/GFAP-MAPK Signaling Pathway
Background Alzheimer’s Disease (AD) is a neurodegenerative disease characterized primarily by gradual memory loss and cognitive decline. With the aging population, the demand for effective treatments for AD is increasingly urgent. The etiology of AD is not fully understood, but known factors include the deposition of Aβ amyloid plaques, neuroinflammation, hyperphosphorylation of tau protein, oxidative … Read more